DK0710483T3 - Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt - Google Patents

Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt

Info

Publication number
DK0710483T3
DK0710483T3 DK95113868T DK95113868T DK0710483T3 DK 0710483 T3 DK0710483 T3 DK 0710483T3 DK 95113868 T DK95113868 T DK 95113868T DK 95113868 T DK95113868 T DK 95113868T DK 0710483 T3 DK0710483 T3 DK 0710483T3
Authority
DK
Denmark
Prior art keywords
peritoneal
chronic renal
treatment
sulodexide
subjected
Prior art date
Application number
DK95113868T
Other languages
Danish (da)
English (en)
Inventor
Gianfranco Tamagnone
Bruno Baggio
Giorgio Bazzato
Agostino Fracasso
Giovanni Gambaro
Egidio Marchi
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of DK0710483T3 publication Critical patent/DK0710483T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
DK95113868T 1994-10-06 1995-09-04 Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt DK0710483T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Publications (1)

Publication Number Publication Date
DK0710483T3 true DK0710483T3 (da) 2001-09-03

Family

ID=11340040

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95113868T DK0710483T3 (da) 1994-10-06 1995-09-04 Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt

Country Status (9)

Country Link
US (1) US5686432A (it)
EP (1) EP0710483B1 (it)
AT (1) ATE202282T1 (it)
DE (1) DE69521388T2 (it)
DK (1) DK0710483T3 (it)
ES (1) ES2157277T3 (it)
GR (1) GR3036158T3 (it)
IT (1) IT1274351B (it)
PT (1) PT710483E (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
KR20020032444A (ko) * 1999-06-30 2002-05-03 잭 허쉬 응괴 연관된 응고 인자를 억제하는 헤파린 조성물
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
US7259152B2 (en) * 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
CA2420890A1 (en) * 2000-09-08 2002-03-14 Hamilton Civic Hospitals Research Development, Inc. Antithrombotic compositions
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
MXPA03011514A (es) * 2001-06-12 2004-10-28 Keryx Biopharmaceuticals Inc Metodos que utilizan glucosaminoglicanos para tratamiento de nefropatia.
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
CN102940622A (zh) 2005-05-30 2013-02-27 弗雷森纽斯医疗护理德国有限责任公司 腹膜透析液
US8372886B2 (en) 2005-12-22 2013-02-12 Kiacta Sarl Treatment of renal disorders, diabetic nephropathy and dyslipidemias
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
CN101883794B (zh) * 2007-10-01 2012-11-07 生化学工业株式会社 低分子化硫酸软骨素及其用途
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
IT1401253B1 (it) * 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
PL177218B1 (pl) * 1993-09-30 1999-10-29 Seikagaku Kogyo Co Ltd Siarczany dermatanu oraz środki przeciwzakrzepowe zawierające siarczany dermatanu

Also Published As

Publication number Publication date
ATE202282T1 (de) 2001-07-15
DE69521388T2 (de) 2001-10-11
ITBO940436A0 (it) 1994-10-06
PT710483E (pt) 2001-09-28
US5686432A (en) 1997-11-11
EP0710483A1 (en) 1996-05-08
ITBO940436A1 (it) 1996-04-06
GR3036158T3 (en) 2001-09-28
IT1274351B (it) 1997-07-17
EP0710483B1 (en) 2001-06-20
ES2157277T3 (es) 2001-08-16
DE69521388D1 (de) 2001-07-26

Similar Documents

Publication Publication Date Title
DK0710483T3 (da) Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt
Joannidis et al. Clinical review: patency of the circuit in continuous renal replacement therapy
Amyot et al. Myoglobin clearance and removal during continuous venovenous hemofiltration
Taylor et al. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients
Johnson et al. Dialysis in the treatment of multiple myeloma
SE8502757L (sv) System for styrning av dialys
IT9067168A0 (it) Apparecchiatura per la depurazione del sangue, particolarmente per il trattamento di pazienti affetti da insufficienza renale, e procedimentoo per produzione di liquido di reinfusione per emodiafiltrazione (hdf)
von Lilien et al. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children
Bunchman et al. Treatment of vancomycin overdose using high-efficiency dialysis membranes
Bellomo et al. Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration
Hory et al. Continuous arteriovenous hemofiltration with low-molecular-weight heparin
Gainza et al. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis
Koup et al. Ceftriaxone pharmacokinetics during peritoneal dialysis
Brown et al. Peritoneal clearance of theophylline
Schrader et al. Long-term intraperitoneal application of low molecular weight heparin in a continuous ambulatory peritoneal dialysis patient with deep vein thrombosis
Gotloib et al. Hemofiltration in severe septic adult respiratory distress syndrome associated with varicella
Rumpf et al. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration
Kessler et al. Dialysis pruritus and sensitization
LEE et al. Clinical Significances of Scrum Protein C and S in Chronic Renal Failure
Aberger et al. Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity
Sethi Prolonged Intermittent Renal Replacement Therapy in Pediatric AKI
Byung-Jin et al. Effect of Erythropoietin on Dialyzer Reuse, Dialysis Efficacy and Other Clinical Parameters
Vaziri et al. Maintenance Hemodialysis in End‐Stage Renal Disease Associated with Spinal Cord Injury
REYNOLDS et al. Survival after 67 days of continuous hemodiafiltration in a patient with multiple system organ failure
Lawless et al. Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone